The role of trimethylamine‐N‐Oxide in the development of Alzheimer's disease
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease is associated with multiple risk factors and is the most common type of dementia. Trimethylamine‐N‐oxide (TMAO), a gut microbiota metabolite derived from dietary choline and carnitine, has recently been identified as a potential risk factor of Alzheimer's disease. It has been demonstrated that TMAO is associated with Alzheimer's disease through various pathophysiological pathways. As a result of molecular crowding effects, TMAO causes the aggregation of the two proteins, amyloid‐beta peptide and tau protein. The aggregation of these proteins is the main pathology associated with Alzheimer's disease. In addition, it has been found that TMAO can activate astrocytes, and inflammatory response. Besides molecular investigation, animal and human studies have also supported the existence of a functional relationship between TMAO and cognitive decline. This article comprehensively summarizes the relationship between TMAO and Alzheimer's disease including emerging evidence from in vitro, in vivo, and clinical studies. We hope that this knowledge will improve the prevention and treatment of Alzheimer's disease in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941 · cited 1×
“It is estimated that there are 44 million cases of AD globally in 2015 and the number is expected to double by 2050 (M. Prince et al., 2013).”
BackgroundDecreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · cited 1×
“Under physiological conditions, the secreted Aβ is eliminated from the brain interstitium by microglia, macrophages, and astrocytes (Frautschy et al., 1998; Mawuenyega et al., 2010; Wisniewski et al., 1991; Wyss‐Coray et al., 2003).”
BackgroundJarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022 · cited 1×
“The aggregated Aβ binds to synaptic receptors, disturbs synapses, and activates neuroinflammation (Jarrett et al., 1993; Lomakin et al., 1997; Lue et al., 2001; Patel et al., 2005; Shankar et al., 2007; Snyder et al., 2005).”
BackgroundKivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 2×
“The aggregated Aβ binds to synaptic receptors, disturbs synapses, and activates neuroinflammation (Jarrett et al., 1993; Lomakin et al., 1997; Lue et al., 2001; Patel et al., 2005; Shankar et al., 2007; Snyder et al., 2005).”
BackgroundRegulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561 · cited 2×
“The aggregated Aβ binds to synaptic receptors, disturbs synapses, and activates neuroinflammation (Jarrett et al., 1993; Lomakin et al., 1997; Lue et al., 2001; Patel et al., 2005; Shankar et al., 2007; Snyder et al., 2005).”
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 2×
“In pathological conditions, tau dysfunction leads to tau oligomerization and fibril formation (Goedert et al., 1989; Grundke‐Iqbal et al., 1986; Ihara et al., 1986; Lee et al., 1991).”
BackgroundNormal aging induces A1-like astrocyte reactivity
Clarke, L. E., Liddelow, S. A., Chakraborty, C., Münch, A. E., Heiman, M., & Barres, B. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800165115 · Cited by 1,237
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134 · cited 1×
“The pathological characteristic of the AD brain is the presence of Aβ plaques and neurofibrillary tangles (S. S. Cho et al., 2011; Glenner & Wong, 1984; Goedert et al., 1988; Masters et al., 1985).”
BackgroundBennett, B. J., Vallim, T. Q. D. A., Wang, Z., Shih, D. M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.011 · Cited by 1,070 · cited 1×
“Thereafter, TMAO enters the systemic circulation via the hepatic vasculature (Bennett et al., 2013; C. E. Cho et al., 2017; Warrier et al., 2015; W. Zhu et al., 2018).”
BackgroundHoltzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Sartorius, L. J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050004797 · Cited by 937 · cited 1×
“Therefore, most animal studies have focused on the hippocampal region, but some studies showed that the pathology of AD in the mouse model began from the cortex (Holcomb et al., 1998; Holtzman et al., 2000).”
BackgroundSeldin, M. M., Meng, Y., Qi, H., Zhu, W., Wang, Z., Hazen, S. L., Lusis, A. J., & Shih, D. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002767 · Cited by 911 · cited 2×
“…high serum levels of TMAO and the progression of small‐vessel diseases, for example, poststroke patients, suggesting that altered perfusion of the brain parenchyma may be involved in TMAO‐ associated neurodegenerative disorders (Y. Liu & Huang, 2015; G. Ma et al., 2017; Seldin et al., 2016).”
BackgroundAdult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818
Wang, Z., Tang, W. H. W., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., Levison, B. S., Fan, Y., Wu, Y., & Hazen, S. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu002 · Cited by 559
Kinetic theory of fibrillogenesis of amyloid β-protein
Lomakin, A., Teplow, D. B., Kirschner, D. A., & Benedek, G. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7942 · Cited by 529
Sun, X., Jiao, X., Ma, Y., Liu, Y., Zhang, L., He, Y., & Chen, Y. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.017 · Cited by 507 · cited 2×
“It has been found that TMAO may aggravate vessel wall inflammation, increase the production of re- active oxygen species, impair cholesterol transport, and alter bile acid metabolism (Ding et al., 2018; Koeth et al., 2013a; Sun et al., 2016).”
BackgroundA Portrait of Alzheimer Secretases--New Features and Familiar Faces
Esler, W. P., & Wolfe, M. S. (2001) · Science · doi:10.1126/science.1064638 · Cited by 493
Li, X. S., Obeid, S., Klingenberg, R., Gencer, B., Mach, F., Räber, L., Windecker, S., Rodondi, N., Nanchen, D., Muller, O., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw582 · Cited by 479
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
Vogt, N. M., Romano, K. A., Darst, B. F., Engelman, C. D., Johnson, S. C., Carlsson, C. M., Asthana, S., Blennow, K., Zetterberg, H., Bendlin, B. B., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0451-2 · Cited by 471
Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline
vom Berg, J., Prokop, S., Miller, K. R., Obst, J., Kälin, R. E., Lopategui-Cabezas, I., Wegner, A., Mair, F., Schipke, C. G., Peters, O., et al. (2012) · Nature Medicine · doi:10.1038/nm.2965 · Cited by 416
The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance
Warrier, M., Shih, D. M., Burrows, A. C., Ferguson, D., Gromovsky, A. D., Brown, A. L., Marshall, S., McDaniel, A., Schugar, R. C., Wang, Z., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.036 · Cited by 414 · cited 4×
“TMAO may be involved in the disease processes through regulation of inflammation, immunity, metabolism, and atherothrombosis (Boini et al., 2017; Koeth et al., 2013b; Warrier et al., 2015).”
BackgroundInfluentialCho, C. E., Taesuwan, S., Malysheva, O. V., Bender, E., Tulchinsky, N. F., Yan, J., Sutter, J. L., & Caudill, M. A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600324 · Cited by 405
Suárez‐Calvet, M., Karikari, T. K., Ashton, N. J., Lantero Rodríguez, J., Milà‐Alomà, M., Gispert, J. D., Salvadó, G., Minguillon, C., Fauria, K., Shekari, M., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012921 · Cited by 401
Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet
Gao, X., Liu, X., Xu, J., Xue, C., Xue, Y., & Wang, Y. (2014) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2014.03.001 · Cited by 360 · cited 1×
“…is an accumulation of evidence to suggest that TMAO has a pathophysiological significance in multiple health conditions, in- cluding metabolic abnormalities, cardiovascular diseases, and neuro- logical disorders (X. Gao et al., 2014; Koeth et al., 2013a; Z. Wang et al., 2011; W. Zhu et al., 2016).”
BackgroundTrimethylamine‐N‐oxide promotes brain aging and cognitive impairment in mice
Li, D., Ke, Y., Zhan, R., Liu, C., Zhao, M., Zeng, A., Shi, X., Ji, L., Cheng, S., Pan, B., et al. (2018) · Aging Cell · doi:10.1111/acel.12768 · Cited by 304 · cited 6×
“The study by Li et al. supported the involvement of the mam- malian target of rapamycin (mTOR) signaling pathway in TMAO‐ induced cognitive impairment, assessed by a novel object recognition test and Y‐maze test (D. Li et al., 2018).”
BackgroundMethodInfluentialTrimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction
Boini, K. M., Hussain, T., Li, P.-L., & Koka, S. S. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000484623 · Cited by 302
Chen, K., Zheng, X., Feng, M., Li, D., & Zhang, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00139 · Cited by 279 · cited 1×
“The elevated levels of plasma TMAO following long‐term high‐fat diet consumption have already been demonstrated in animal and clinical studies (Boutagy et al., 2015; Chen et al., 2017; Sanguinetti et al., 2018).”
BackgroundInfluentialWestin, K., Buchhave, P., Nielsen, H., Minthon, L., Janciauskiene, S., & Hansson, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030525 · Cited by 277
Ma, G., Pan, B., Chen, Y., Guo, C., Zhao, M., Zheng, L., & Chen, B. (2017) · Bioscience Reports · doi:10.1042/bsr20160244 · Cited by 267
Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism
Ding, L., Chang, M., Guo, Y., Zhang, L., Xue, C., Yanagita, T., Zhang, T., & Wang, Y. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0939-6 · Cited by 250 · cited 1×
“In AD, astrocytes can be activated either directly by Aβ plaques and neurofibrillary tangles or indirectly by pro‐inflammatory cytokines, resulting in further secretion of astrocyte‐derived chemokines and cytokines (Echeverria et al., 2016; Westin et al., 2012).”
BackgroundRiemenschneider, M., Wagenpfeil, S., Vanderstichele, H., Otto, M., Wiltfang, J., Kretzschmar, H., Vanmechelen, E., Förstl, H., & Kurz, A. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001220 · Cited by 238 · cited 1×
“Tau aggregation in the brain can be found in many neurodegenerative diseases (Riemenschneider et al., 2003; Savica et al., 2013).”
BackgroundMartínez-del Campo, A., Bodea, S., Hamer, H. A., Marks, J. A., Haiser, H. J., Turnbaugh, P. J., & Balskus, E. P. (2015) · mBio · doi:10.1128/mbio.00042-15 · Cited by 224
Entropic Stabilization of Proteins by TMAO
Cho, S. S., Reddy, G., Straub, J. E., & Thirumalai, D. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp207289b · Cited by 198 · cited 3×
“TMAO was found to facilitate peptide folding and stabilize folded peptide structures by acting as a “molecular crow- der” (Canchi et al., 2012; S. S. Cho et al., 2011; J. Ma et al., 2014; Sagle et al., 2011).”
BackgroundBrunt, V. E., LaRocca, T. J., Bazzoni, A. E., Sapinsley, Z. J., Miyamoto-Ditmon, J., Gioscia-Ryan, R. A., Neilson, A. P., Link, C. D., & Seals, D. R. (2021) · GeroScience · doi:10.1007/s11357-020-00257-2 · Cited by 197 · cited 1×
“The normal aging process may also lead to an increase in plasma TMAO (Brunt et al., 2020, 2021.”
BackgroundTerwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J.-Å., Holtzman, D. M., & Heneka, M. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6546-10.2011 · Cited by 190
Towards understanding brain-gut-microbiome connections in Alzheimer’s disease
Xu, R., & Wang, Q. (2016) · BMC Systems Biology · doi:10.1186/s12918-016-0307-y · Cited by 175
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid
Del Rio, D., Zimetti, F., Caffarra, P., Tassotti, M., Bernini, F., Brighenti, F., Zini, A., & Zanotti, I. (2017) · Nutrients · doi:10.3390/nu9101053 · Cited by 172
Zhu, W., Buffa, J. A., Wang, Z., Warrier, M., Schugar, R., Shih, D. M., Gupta, N., Gregory, J. C., Org, E., Fu, X., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14234 · Cited by 161
Probiotic supplementation and trimethylamine‐N‐oxide production following a high‐fat diet
Boutagy, N. E., Neilson, A. P., Osterberg, K. L., Smithson, A. T., Englund, T. R., Davy, B. M., Hulver, M. W., & Davy, K. P. (2015) · Obesity · doi:10.1002/oby.21212 · Cited by 127 · cited 1×
“The elevated levels of plasma TMAO following long‐term high‐fat diet consumption have already been demonstrated in animal and clinical studies (Boutagy et al., 2015; Chen et al., 2017; Sanguinetti et al., 2018).”
BackgroundInfluentialEidenmüller, J., Fath, T., Hellwig, A., Reed, J., Sontag, E., & Brandt, R. (2000) · Biochemistry · doi:10.1021/bi001290z · Cited by 117 · cited 2×
“TMAO was found to enhance the process of the assembly of tubulin into microtubules via enzyme‐dependent tau dephosphorylation and modification of the secondary structure of tau at its C‐terminal fragment (Eidenmüller et al., 2000; Scaramozzino et al., 2006; Smith et al., 2000; Tseng et al., 1999).”
BackgroundGut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress
Govindarajulu, M., Pinky, P. D., Steinke, I., Bloemer, J., Ramesh, S., Kariharan, T., Rella, R. T., Bhattacharya, S., Dhanasekaran, M., Suppiramaniam, V., et al. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00138 · Cited by 113
Yilmaz, A., Ugur, Z., Bisgin, H., Akyol, S., Bahado-Singh, R., Wilson, G., Imam, K., Maddens, M. E., & Graham, S. F. (2020) · Metabolites · doi:10.3390/metabo10090357 · Cited by 65 · cited 2×
“CSF from AD patients showed increased TMAO levels compared with CSF from normal individuals, and the increased TMAO levels were correlated with the pattern associated with AD, specifically, a decreased amyloid‐beta, which is indicative of deposition of Aβ in the brain, an elevation in phosphorylated‐tau, total‐tau, an…”
Background
Cited by
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO
Tu, R., & Xia, J. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230203140805 · Cited by 47
Gut microbiome and Alzheimer’s disease: What we know and what remains to be explored
Kapoor, B., Biswas, P., Gulati, M., Rani, P., & Gupta, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102570 · Cited by 46
Zhang, Y., Wang, G., Li, R., Liu, R., Yu, Z., Zhang, Z., & Wan, Z. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2022.105459 · Cited by 37
Zhou, S., Liu, J., Sun, Y., Xu, P., Liu, J. L., Sun, S., Zhu, B., & Wu, H. (2023) · Food & Function · doi:10.1039/d2fo03874a · Cited by 34
Metadata
- Authors
- Buawangpong, N., Pinyopornpanish, K., Siri‐Angkul, N., Chattipakorn, N., & Chattipakorn, S. C.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2021-11-23
- Volume
- 237
- Issue
- 3
- Pages
- 1661-1685
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W3216633157
- Cited by
- 60
- References
- 43
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.